Jan 14, 2020
RESMETIROM
RESMETIROM
C17H12Cl2N6O4
435.2 g/mol
MGL-3196
CAS 920509-32-6, Resmetirom, VIA-3196, UNII-RE0V0T1ES0
Phase III, Non-alcoholic fatty liver disease (NAFLD)
2-[3,5-dichloro-4-[(6-oxo-5-propan-2-yl-1H-pyridazin-3-yl)oxy]phenyl]-3,5-dioxo-1,2,4-triazine-6-carbonitrile
2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-(1,2,4)TRIAZINE-6-CA…
View On WordPress